EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy

Nicola Specchio, Rima Nabbout, Eleonora Aronica, Stephane Auvin, Arianna Benvenuto, Luca de Palma, Martha Feucht, Floor Jansen, Katarzyna Kotulska, Harvey Sarnat, Lieven Lagae, Sergiusz Jozwiak und 1 weitere

European Journal of Paediatric Neurology · 2023-11 · 47 · 25-34

DOI: 10.1016/j.ejpn.2023.08.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Paediatric Neurology, 2023-11. Verfasst von Nicola Specchio und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Neurology, Bambino Gesu' Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsie…. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Autism Spectrum Disorder, Epilepsy, Drug Resistant Epilepsy. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children with tuberous sclerosis complex (TSC), may experience a variety of seizure types in the first year of life, most often focal seizure sand epileptic spasms. Drug resistance is seen early in many patients, and the management of TSC associated epilepsy remain a major challenge for clinicians. In 2018 clinical recommendations for the management of TSC associated epilepsy were published by a panel of European experts. In the last five years considerable progress has been made in understanding the neurobiology of epileptogenesis and three interventional randomized controlled trials have changed the therapeutic approach for the management of TSC associated epilepsy. Pre-symptomatic treatment with vigabatrin may delay seizure onset, may reduce seizure severity and reduce the risk of epileptic encephalopathy. The efficacy of mTOR inhibition with adjunctive everolimus was documented in patients with TSC associated refractory seizures and cannabidiol could be another therapeutic option. Epilepsy surgery has significantly improved seizure outcome in selected patients and should be considered early in all patients with drug resistant epilepsy. There is a need to identify patients who may have a higher risk of developing epilepsy and autism spectrum disorder (ASD). In the recent years significant progress has been made owing to the early identification of risk factors for the development of drug-resistant epilepsy. Better understanding of the mechanism underlying epileptogenesis may improve the management for TSC-related epilepsy. Developmental neurobiology and neuropathology give opportunities for the implementation of concepts related to clinical findings, and an early genetic diagnosis and use of EEG and MRI biomarkers may improve the development of pre-symptomatic and disease-modifying strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous SclerosisAutism Spectrum DisorderEpilepsyDrug Resistant EpilepsyChildHumansSeizures

Stichwörter der Autor:innen

Developmental and epileptic encephalopathiesDrug resistant epilepsyEpileptogenesisEverolimusNeurodevelopmental disordersPre-symptomatic treatment

Autor:innen und Institutionen

  • Clinical and Experimental Neurology, Bambino Gesu' Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Rome, Italy. Electronic address: nicola.specchio@opbg.net.
  • Department of Pediatric Neurology, Necker Enfants Malades Hospital, Université Paris Cité, Member of the European Reference Network on Rare and Complex Epilepsies EpiCARE, INSERM U1163, Institut Imagine, Paris, France.
  • Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Department of (Neuro)Pathology, Amsterdam, Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
  • APHP, Service de Neurologie Pédiatrique, Centre Epilepsies Rares, Member of the European Reference Network on Rare and Complex Epilepsies EpiCARE, Hôpital Robert Debré, Paris, France; Université Paris-Cité, INSERM Neuro…
  • Libera Università Maria Santissima Assunta (LUMSA), Rome, Italy.
  • Clinical and Experimental Neurology, Bambino Gesu' Children's Hospital IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE, Rome, Italy.

Zitieren

APA

Specchio, N., Nabbout, R., Aronica, E., Auvin, S., Benvenuto, A., de Palma, L., Feucht, M., Jansen, F., Kotulska, K., Sarnat, H., Lagae, L., Jozwiak, S., & Curatolo, P. (2023). Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. European Journal of Paediatric Neurology, 47, 25-34. https://doi.org/10.1016/j.ejpn.2023.08.005

Vancouver

Specchio N, Nabbout R, Aronica E, Auvin S, Benvenuto A, de Palma L, et al. Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. European Journal of Paediatric Neurology. 2023;47:25-34. doi:10.1016/j.ejpn.2023.08.005

BibTeX
@article{Specchio2023,
  author = {Specchio, Nicola and Nabbout, Rima and Aronica, Eleonora and Auvin, Stephane and Benvenuto, Arianna and de Palma, Luca and Feucht, Martha and Jansen, Floor and Kotulska, Katarzyna and Sarnat, Harvey and Lagae, Lieven and Jozwiak, Sergiusz and Curatolo, Paolo},
  title = {Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy},
  journal = {European Journal of Paediatric Neurology},
  year = {2023},
  volume = {47},
  pages = {25--34},
  doi = {10.1016/j.ejpn.2023.08.005}
}
Kostenlos starten →